FC9402 is a potent and selective sulfide quinone oxidoreductase (SQOR) inhibitor extracted from patent WO 2020/146636 A1. FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis. FC9402 can be used for cardiovascular regulation[1].
IC50&Target
SQOR[1]
体外研究
FC9402 can alleviate TAC induced cardiomyocyte hypertrophy and left ventricular (LV) fibrosis [1].
分子式
C19H16N4O
分子量
316.36
CAS号
2452401-65-7
中文名称
4-(4-氨基苯基)-6-甲氧基-3'-甲基-[2,2'-联吡啶]-5-腈
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)